Medical Specimen Collection is categorized under Drug Detection Service and Equipment in Anchorage, AK .
Medical Specimen Collection was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Drug Detection Service and Equipment business, which does work in the B2C market, and is classified as a Drug Detection Service and Equipment, under code number 6215110 by the NAICS.
If you are seeking more information, feel free to contact Michael Martin, Owner at the company’s single location by writing to Po Box 141642, Anchorage, Alaska AK 99514 or by phoning (907) 222-5404. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Medical Specimen Collection |
| Contact Person: | Michael Martin, Owner |
| Address: | Po Box 141642, Anchorage, Alaska 99514 |
| Phone Number: | (907) 222-5404 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Drug Detection Service and Equipment |
| SIC Code: | 8071 |
| NAICS Code: | 6215110 |
| Share This Business: |
Medical Specimen Collection was started in 0 to provide professional Drug Detection Service and Equipment under the SIC code 8071 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Michael Martin, Owner for inquiries that concern Medical Specimen Collection by calling the company number (907) 222-5404, as your correspondence is most welcome. Additionally, the physical location of the single location of Medical Specimen Collection can be found at the coordinates 61.214251,-149.810956 as well as the street address Po Box 141642 in Anchorage, Alaska 99514.
For its online presence, you may visit Medical Specimen Collection’s website at and engage with its social media outlets through on Twitter and on Facebook.